1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Ibuprofen Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Country/Region, 2017, 2022 & 2028
2.2 Intravenous (IV) Ibuprofen Segment by Type
2.2.1 100 mg Dose
2.2.2 200 mg Dose
2.2.3 400 mg Dose
2.2.4 800 mg Dose
2.3 Intravenous (IV) Ibuprofen Sales by Type
2.3.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous (IV) Ibuprofen Sale Price by Type (2017-2022)
2.4 Intravenous (IV) Ibuprofen Segment by Application
2.4.1 Pain
2.4.2 Fever
2.4.3 Inflammation
2.5 Intravenous (IV) Ibuprofen Sales by Application
2.5.1 Global Intravenous (IV) Ibuprofen Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous (IV) Ibuprofen Sale Price by Application (2017-2022)
3 Global Intravenous (IV) Ibuprofen by Company
3.1 Global Intravenous (IV) Ibuprofen Breakdown Data by Company
3.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Company (2020-2022)
3.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Company (2020-2022)
3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous (IV) Ibuprofen Sale Price by Company
3.4 Key Manufacturers Intravenous (IV) Ibuprofen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous (IV) Ibuprofen Product Location Distribution
3.4.2 Players Intravenous (IV) Ibuprofen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous (IV) Ibuprofen by Geographic Region
4.1 World Historic Intravenous (IV) Ibuprofen Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Geographic Region
4.2 World Historic Intravenous (IV) Ibuprofen Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous (IV) Ibuprofen Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Country/Region
4.3 Americas Intravenous (IV) Ibuprofen Sales Growth
4.4 APAC Intravenous (IV) Ibuprofen Sales Growth
4.5 Europe Intravenous (IV) Ibuprofen Sales Growth
4.6 Middle East & Africa Intravenous (IV) Ibuprofen Sales Growth
5 Americas
5.1 Americas Intravenous (IV) Ibuprofen Sales by Country
5.1.1 Americas Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
5.1.2 Americas Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
5.2 Americas Intravenous (IV) Ibuprofen Sales by Type
5.3 Americas Intravenous (IV) Ibuprofen Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Ibuprofen Sales by Region
6.1.1 APAC Intravenous (IV) Ibuprofen Sales by Region (2017-2022)
6.1.2 APAC Intravenous (IV) Ibuprofen Revenue by Region (2017-2022)
6.2 APAC Intravenous (IV) Ibuprofen Sales by Type
6.3 APAC Intravenous (IV) Ibuprofen Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous (IV) Ibuprofen by Country
7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
7.2 Europe Intravenous (IV) Ibuprofen Sales by Type
7.3 Europe Intravenous (IV) Ibuprofen Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous (IV) Ibuprofen by Country
8.1.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Type
8.3 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen
10.3 Manufacturing Process Analysis of Intravenous (IV) Ibuprofen
10.4 Industry Chain Structure of Intravenous (IV) Ibuprofen
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous (IV) Ibuprofen Distributors
11.3 Intravenous (IV) Ibuprofen Customer
12 World Forecast Review for Intravenous (IV) Ibuprofen by Geographic Region
12.1 Global Intravenous (IV) Ibuprofen Market Size Forecast by Region
12.1.1 Global Intravenous (IV) Ibuprofen Forecast by Region (2023-2028)
12.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous (IV) Ibuprofen Forecast by Type
12.7 Global Intravenous (IV) Ibuprofen Forecast by Application
13 Key Players Analysis
13.1 Cumberland Pharmaceuticals
13.1.1 Cumberland Pharmaceuticals Company Information
13.1.2 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Cumberland Pharmaceuticals Main Business Overview
13.1.5 Cumberland Pharmaceuticals Latest Developments
13.2 Alveda Pharmaceuticals
13.2.1 Alveda Pharmaceuticals Company Information
13.2.2 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alveda Pharmaceuticals Main Business Overview
13.2.5 Alveda Pharmaceuticals Latest Developments
13.3 CSL Limited
13.3.1 CSL Limited Company Information
13.3.2 CSL Limited Intravenous (IV) Ibuprofen Product Offered
13.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Limited Main Business Overview
13.3.5 CSL Limited Latest Developments
13.4 Sandor Medicaids
13.4.1 Sandor Medicaids Company Information
13.4.2 Sandor Medicaids Intravenous (IV) Ibuprofen Product Offered
13.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sandor Medicaids Main Business Overview
13.4.5 Sandor Medicaids Latest Developments
13.5 PT. Soho Industri Pharmasi
13.5.1 PT. Soho Industri Pharmasi Company Information
13.5.2 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offered
13.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 PT. Soho Industri Pharmasi Main Business Overview
13.5.5 PT. Soho Industri Pharmasi Latest Developments
13.6 Germin MED
13.6.1 Germin MED Company Information
13.6.2 Germin MED Intravenous (IV) Ibuprofen Product Offered
13.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Germin MED Main Business Overview
13.6.5 Germin MED Latest Developments
13.7 Grifols
13.7.1 Grifols Company Information
13.7.2 Grifols Intravenous (IV) Ibuprofen Product Offered
13.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Grifols Main Business Overview
13.7.5 Grifols Latest Developments
13.8 Gloria Pharmaceuticals
13.8.1 Gloria Pharmaceuticals Company Information
13.8.2 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Gloria Pharmaceuticals Main Business Overview
13.8.5 Gloria Pharmaceuticals Latest Developments
13.9 Al Nabeel International
13.9.1 Al Nabeel International Company Information
13.9.2 Al Nabeel International Intravenous (IV) Ibuprofen Product Offered
13.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Al Nabeel International Main Business Overview
13.9.5 Al Nabeel International Latest Developments
13.10 Laboratorios Valmorca
13.10.1 Laboratorios Valmorca Company Information
13.10.2 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offered
13.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Laboratorios Valmorca Main Business Overview
13.10.5 Laboratorios Valmorca Latest Developments
14 Research Findings and Conclusion
【掲載企業】
Cumberland Pharmaceuticals、 Alveda Pharmaceuticals、 CSL Limited、 Sandor Medicaids、 PT. Soho Industri Pharmasi、 Germin MED、 Grifols、 Gloria Pharmaceuticals、 Al Nabeel International、 Laboratorios Valmorca